machealth.ca
Join Group

Opioids Clinical Primer

This six-part program provides an overview of key concepts and skills for clinicians facing common challenges in the management of patients with chronic pain, including reducing the risks of opioids and addressing opioid use disorder.

This six-part program provides an overview of key concepts and skills for clinicians facing common challenges in the management of patients with chronic pain, including reducing the risks of opioids and addressing opioid use disorder.

Managing Opioid Use Disorder

Explore our three courses below. Don’t forget to explore the resource section and our other related courses on managing chronic pain.

Not a member yet? Not a problem.
Sign Up Now
Courses
Opioid Use Disorder in Primary Care: Principles of Assessment and Management
Review the role of opioids in the brain and the signs and symptoms of withdrawal. Learn how to identify patients with opioid use disorder and outline the management options for opioid use disorder including the role of opioid agonist therapy with buprenorphine. Educate patients on strategies to prevent opioid overdose including the use of naloxone, a vital tool for overdose prevention.
Managing Patients with Opioid Use Disorder in Primary Care with Buprenorphine
Using case studies, learn how to identify patients who would benefit from buprenorphine treatment in a primary care setting. Understand how to manage buprenorphine prescriptions, including; dose adjustments, side effect management, monitoring, observed versus take-home dosing, the role of urine drug testing. Learn about the importance of co-morbid mood and anxiety disorders with respect to relapse prevention and the importance of trauma histories in relation to opioid use disorder.
Treating Opioid Use Disorder: Initiating Buprenorphine in Primary Care, ED and Inpatient Settings
Learn how to identify patients with opioid use disorder in primary care, emergency departments and inpatient settings. Use tailored case studies to learn how to safely initiate treatment with buprenorphine/naloxone in these different clinical environments.